SUBJECT INDEX SI17
in diathesis-stress model,
26–27
discrimination, 64
in disruptive behavior and
attention disorders,
663–664
in dissociative amnesia, 337
in dissociative fugue, 339–340
in dissociative identity
disorder, 347, 349–351
in DSM-IV-TR, 85
in eating disorders, 455–460,
466–468
family, 60–62
feedback loops in, 66–67
in gender identity disorder,
479–480, 481
in generalized anxiety
disorder, 256, 260
in hypochondriasis, 369
in learning disorders, 646
in mental retardation, 630
in obsessive-compulsive
disorder, 305–306, 309
in panic disorder, 271,
275–276
in paraphilias, 492
in personality disorders, 580,
589, 597, 607
in posttraumatic stress
disorder, 323–324
research on, 172–174
in schizophrenia, 549–553,
560–562
in sexual dysfunctions, 507,
510, 512
in social phobia, 284, 287–288
social stressors, 63–65
in somatization disorder, 358
in specifi c phobias, 294, 297
in substance use disorders,
402–403, 410–411, 418
in suicide, 237–239, 238t, 241
treatment targeting, 110t,
135–148, 186–188
in younger and older
populations, 142–143
Social inhibition, 613–615
Social isolation, 62
Social phobia
amygdala in, 91
avoidant personality disorder
vs., 614–615
defi nition of, 278–279
extinction for, 126
feedback loops in, 284–285,
285f, 288, 288f
generalized, 279
group therapy for, 139
neurological factors in,
281–282, 286
operant conditioning in,
52–53
psychological factors in,
283–284, 286–287
social factors in, 284,
287–288
treatment of, 148–149,
285–288
Social phobia (social anxiety
disorder), 278–289
Social rhythms, 229f, 230
Social selection, 63–64
in schizophrenia, 552
Social skills
in schizophrenia, 525–526,
549–550
Social skills training
for personality disorders, 591
schizophrenia and, 561
Social support, 62–63
posttraumatic stress disorder
and, 321
Social workers, 87, 87t
Sociocognitive model
on dissociative identity
disorder, 348, 350
Socioeconomic status (SES),
63–64
assessment and, 103
depression and, 206
disruptive behavior disorders
and, 664
in personality disorders, 594
in posttraumatic stress
disorder, 320–321
in schizophrenia, 537, 552
in somatization disorder, 358
substance use disorders and,
403
Somatic delusions, 6, 531
Somatic disorders
koro, 8, 9
Somatization disorder, 354–359,
374t
anxiety disorders with, 251
diagnostic reliability and, 373
Somatoform disorders, 352–377
body dysmorphic disorder,
353, 369–373
conversion disorder, 360–365
criticism of concept of, 373
defi nition of, 332, 353
feedback loops in, 376, 376f
hypochondriasis, 353,
365–369
neurological factors in, 353
psychological factors in, 353
somatization disorder,
354–359
treatment of, 373–376, 374t,
375t
Somatosensory cortex, 292
Something’s Not Right
(Lelewer), 644
Specifi c attributions, 204–205,
204t
Specifi c factors, 178, 183–184
Specifi c phobias, 289–298
animal, 290
defi nition of, 289–291
feedback loops in, 294–295,
295f, 297–298, 298f
natural environment, 290neurological factors in,
292–293, 296
other type, 291
psychological factors in,
293–294, 296–297
racial/ethnic differences in, 174
situational, 291
social factors in, 294, 297
treatment of, 296–298
Specifi ers, 196–197
Speech
alogia, 523, 558
clinical assessment of, 95
disorganized, in
schizophrenia, 520,
522–523
Spielberg, Stephen, 531
Squeeze technique, 512
SSRIs.See Selective serotonin-
reuptake inhibitors (SSRIs)
Stable attributions, 204–205,
204t
Stages of change theory,
424–425
Stage theory, 386–387
Standards, community, 174
Starr, Ringo, 381, 404
Startle response, 321
Starvation study, 440–441
Statistical signifi cance, 161–162
Stereotyped behaviors, 629–630,
635
tics vs., 676
Stigma, 76, 77, 144
StigmaBusters, 77
Stimulants, 391–403
for attention-defi cit/
hyperactivity disorder,
666
treatment of abuse of, 422,
424t
amphetamines, 392–393
cocaine and crack, 391–392
MDMA (Ecstasy), 394
methamphetamine, 393
neurological factors in,
395–399
nicotine, 395
psychological factors and,
399–401
Ritalin, 394
social factors in, 402–403
Stimulus control, 125
Stimulus generalization, 49f
St. John’s wort, 211
for somatoform disorders, 373
Strattera, 113, 666
Stress
bipolar disorders and, 226
from bullying, 64–65
child maltreatment and, 61
in conversion disorder, 363
in depressive disorders,
201–202, 205–206
in diathesis-stress model,
26–27
dissociative fugue and, 339in dissociative identity
disorder, 344
maternal, schizophrenia and,
543
from military service and
war, 65
in obsessive-compulsive
disorder, 305–306
panic disorder and, 271
in schizophrenia, 545,
550–551
social factors and, 24–25
social support and, 62
socioeconomic status and,
63–64
in somatization disorder, 358
suicide and, 239
traumatic, 311–313
Stress–diathesis model, 26–27
of depression, 201–202, 206
on schizophrenia, 554–555
Stress disorders, 311
acute, 314
posttraumatic stress disorder,
311–326
acute, 311
Stress-reactive rumination,
203–204
Stress response, 35, 249–251,
250f
in conversion disorder, 365
in hypochondriasis, 369
Stroke, 682, 687–688, 708
Structured Clinical Interview for
DSM-IV, Axes I and II, 98
Structured interviews, 94–95
Styron, William, 194
Subclinical symptoms, 304
Subcortical areas, 36–37, 37f
Subcultures, 9
Sublimation, 20f
Suboxone, 423
Substance abuse
amnestic disorder from, 697
in borderline personality
disorder, 604
conduct disorder and, 650
continuum of, 387
dangerousness and, 730
defi nition of, 383
delirium from, 692
dependence and, 383–389
diagnostic criteria for, 383
experiments studying, 157
polysubstance, 388
substance use disorders, 5,
381–433
suicide and, 234, 239
Substance dependence, 383–389
defi nition of, 383
diagnostic criteria for, 384
Substance-induced persisting
amnestic disorder, 697
Substance-induced persisting
dementia, 710, 710t
Substance intoxication, 382
Substance P, 93